微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 86.41% | 1.8% | -0.22% | 13/159 | 50.44% | 迪哲医药 | 99.22% | 行业排名> |
| 2026-06-30 | 86.6% | 2.15% | 1.17% | 10/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 85.6% | 1.27% | 0.93% | 13/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 84.81% | 2.43% | -0.08% | 16/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 84.88% | 3.22% | 0.11% | 14/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 84.79% | 4.02% | 0.3% | 14/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 84.53% | 2.58% | 2.09% | 12/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 82.8% | 1.46% | 0.7% | 18/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 82.23% | 0.66% | 0.88% | 17/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 81.51% | 0.23% | -1.08% | 19/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 82.4% | 2.42% | 0.98% | 16/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 81.61% | -0.11% | -0.1% | 18/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 81.69% | -0.36% | 0.45% | 20/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 81.32% | -1.41% | 1.08% | 21/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 80.45% | -5.51% | -1.53% | 25/159 | 52.66% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 81.7% | -11.63% | -0.34% | 18/159 | 53.51% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 81.98% | 2% | -0.61% | 18/159 | 5.67% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 82.49% | 2% | -3.12% | 20/159 | 20.91% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 85.14% | 2% | -7.9% | 13/159 | 54.06% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 92.45% | 2% | 2% | 8/159 | 54.9% | 首药控股 | 99.93% | 行业排名> |